Structure-activity relationships for the degradation reaction of 1-β-O-acyl glucuronides. Part 3: Electronic and steric descriptors predicting the reactivity of aralkyl carboxylic acid 1-β-O-acyl glucuronides

Chemical Research in Toxicology

Volumn 22, Issue 12, 2009, Pages 1998-2008

  Baba, Akiko ^a   Yoshioka, Tadao ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 BETA O ACYL GLUCORONIDE DERIVATIVE; ARYLPROPIONIC ACID DERIVATIVE; CARBOXYLIC ACID; GLUCURONIDE; HYDROGEN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; NUCLEAR MAGNETIC RESONANCE; PREDICTION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; VALIDATION STUDY;

GLUCURONIDES; ISOMERISM; KINETICS; PROTEIN BINDING; PROTEINS; REGRESSION ANALYSIS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 73849085977     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx9002963     Document Type: Article

References (75)

1. Kalgutkar, A. S., Gardner, I., Obach, R, S., Shaffer, C. L., Callegari, E., Henne, K. R., Mutlib, A. E., Dalvie, D. K., Lee, J. S., Nakai, Y., O'Donnell, J. P., Boer, J., and, and Harriman, S. P. (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 6, 161-225.
2. Walgren, J. L., Mitchell, M. D., and Thompson, D. C. (2005) Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit. Rev. Toxicol. 35, 325-361.
3. Zhou, S., Chan, E., Duan, W., Huang, M, and Chen, Y.-Z. (2005) Drug bioactivation, covalent binding to target proteins and toxicological relevance. Drug Metab. Rev. 37, 41-213.
4. Smith, D. A., and Obach, R. S. (2006) Metabolites and safety: what are the concerns, and how should we address them? Chem. Res. Toxicol. 19, 1570-1579.
5. Guengerich, F. P., and MacDonald, J. S. (2007) Applying mechanisms of chemical toxicity to predict drug safety. Chem. Res. Toxicol. 20, 344-369.
6. Kalgutkar, A. S., Obach, R. S., and Maurer, T. S. (2007) Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationships to clinical drug-drug interactions and idiosyncratic adverse drug reactions. Curr. Drug Metab. 8, 407-447.
7. Shu, Y.-Z., Johnson, B. M., and Yang, T. J. (2008) Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. AAPS J. 10, 178-192.
8. Park, B. K., Pirmohamed, M., and Kitteringham, N. R. (1998) Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol. 11, 969-988.
9. Boelsterli, U. A. (2003) Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol. Appl. Pharmacol. 192, 307-322.
10. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16.
11. Hussaini, S. H., and Farrington, E. A. (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opin. Drug Saf. 6, 673-684.
12. Uetrecht, J. (2008) Idiosyncratic drug reactions: past, present, and future. Chem. Res. Toxicol. 21, 84-92.
13. Uetrecht, J. (2009) Immune-mediated adverse drug reactions. Chem. Res. Toxicol. 22, 24-34.
14. Baillie, T. A. (2008) Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem. Res. Toxicol. 21, 129-137.
15. Smith, D. A., and Obach, R. (2009) Metabolites in safety testing (MIST); Considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. Chem. Res. Toxicol. 22, 267-279.
16. Fung, N., Thornton, A., Mybeck, K., Wu, J. H.-H., Hornbuckle, K., and Muniz, E. (2001) Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999. Drug Inf. J. 35, 293-317.
17. Wysowski, D. K., and Swarz, L. (2005) Adverse drug event surveillance and drug withdrawals in the Unites States 1969-2002. Arch. Intern. Med. 165, 1363-1369.
18. Smith, D. A., and Schmid, E. F. (2006) Drug withdrawals and lessons within. Curr. Opin. Drug Discovery Dev. 9, 38-46.
19. Faed, E. M. (1984) Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15, 1213-1249.
20. Sphan, L., and Benet, L. Z. (1992) Acyl glucuronides revised: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev. 24, 5-47.
21. Fenselau, C. (1994) Acyl Glucuronides as Chemically Reactive Intermediates, in Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity (Handbook of Experimental Pharmacology) (Kauffman F. C., Ed.) Vol. 112, pp 367-389, Springer-Verlag, Berlin, Germany.
22. Hayball, P. J. (1995) Formation and reactivity of acyl glucuronides: the influence of chirality. Chirality 7, 1-9.
23. Shipkova, M., Armstrong, V. W., Oellerich, M., and Wieland, E. (2003) Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther. Drug Monit. 25, 1-16.
24. Bailey, M. J., and Dickinson, R. G. (2003) Acyl glucuronide reactivity in perspective: biological consequences. Chem.-Biol. Interact. 145, 117-137.
25. Yang, X.-X., Hu, Z.-P., Boelsterli, U. A., and Zhou, S.-F. (2006) Drug acyl glucuronides: Reactivity and analytical implication. Curr. Pharm. Anal. 2, 259-277.
26. Stachulski, A. W. (2007) The chemistry and biological activity of acyl glucuronides. Curr. Opin. Drug Discovery Dev. 10, 58-66.
27. Skonberg, C., Olsen, J., Madsen, K. G., Hansen, S. H., and Grillo, M. P. (2008) Metabolic activation of carboxylic acids. Expert Opin. Drug Metab. Toxicol. 4, 425-438.
28. Tang, W., Stearns, R. A., Wang, R. W., Chiu, S.-H. L., and Baillie, T. A. (1999) Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem. Res. Toxicol. 12, 192-199.
29. Shen, S., Marchick, M. R., Davis, M. R., Doss, G. A., and Pohl, L. R. (1999) Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 6-hydroxydiclofenac. Chem. Res. Toxicol. 12, 214-222.
30. Ju, C, and Uetrecht, J. P. (1998) Oxidation of a metabolite of indomethacin (desmethyl-deschlorobenzoylindomethacin) to reactive intermediates by activated neurophiles, hypochlorous acid, and the myeloperoxidase system. Drug Metab. Dispos. 26, 676-680.
31. O'Donnell, J. P., Dalvie, D. K., Kalgutkar, A. S., and Obach, R. S. (2003) Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen. Drug Metab. Dispos. 31, 1369-1377.
32. Williams, D. P., Antoine, D. J., Butler, P. J., Jones, R., Randle, L., Payne, A., Howard, M., Gardner, I., Blagg, J., and Park, B. K. (2007) The metabolism and toxicity of furosemide in the Wister rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J. Pharmacol. Exp. Ther. 322, 1208-1220.
33. Ogilive, B. W., Zhang, D. Li, W., Rodrigues, A. D., Gipson, A. E., Holsapple, J., Toren, P., and Parkinson, A. (2006) Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interaction. Drug Metab. Dispos. 34, 191-197.
34. Baer, B. B., DeLisle, R. K., and Allen, A. (2009) Benzylic oxidation of gemfibrozil-1-O-β-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition. Chem. Res. Toxicol. 22, 1298-1309.
35. Olsen, J., Li, C., Skonberg, C., Bjørnsdottir, I., Sidenius, U., Benet, L. Z., and Hansen, S. H. (2007) Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme A thioester intermediate in rats. Drug Metab. Dispos. 35, 758-764.
36. Grillo, M. P., and Hua, F. (2008) Enantioselective formation of ibuprofen-S-acyl-glutathione in vitro in incubations of ibuprofen with rat hepatocytes. Chem. Res. Toxicol. 21, 1749-1759.
37. van Breemen, R. B., and Fenselau, C. (1985) Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Dispos. 13, 318-320.
38. Smith, P. C., Benet, L. Z., and McDonagh, A. F. (1990) Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab. Dispos. 18, 639-644.
39. Benet, L. Z., Spahn-Langguth, H., Iwakawa, S., Volland, C., Mizuma, T., Mayer, S., Mutschler, E., and Lin, E. T. (1993) Predictability of the covalent binding of acidic drugs in man. Life Sci. 53, 141-146.
40. Bolze, S., Bromet, N., Gay-Feutry, C., Massiere, F., Boulieu, R., and Hulot, T. (2002) Development of an in vitro screening model for the biosynthesis of acyl glucuronide metabolites and the assessment of their reactivity toward human serum albumin. Drug Metab. Dispos. 30, 404-413.
41. Wang, J., Davis, M., Li, F., Azam, F., Scatina, J., and Talaat, R. (2004) A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: Development of rapidly formed peptide adducts for LC/MS/MS measurements. Chem. Res. Toxicol. 17, 1206-1216.
42. Vanderhoeven, S. J., Troke, J., Tranter, G. E.,Wilson, I. D., Nicholson, J. K., and Lindon, J. C. (2004) Nuclear magnetic resonance (NMR) and quantitative structure-activity relationship (QSAR) studies on the transacylation reactivity of model 1β-O-acyl glucuronides II: QSAR modelling of the reaction using both computational and experimental NMR parameters. Xenobiotica 34, 889-900.
43. Sidelmann, U., Hansen, S. H., Gavaghan, C., Nicholls, A. W., Carless, H. A. J., Lindon, J. C., Wilson, I. D., and Nichlson, J. K. (1996) Development of a simple liquid chromatographic method for the separation of mixtures of positional isomers and anomers of synthetic 2-, 3- and 4-fluorobenzoic acid glucuronides formed via acyl migration reactions. J. Chromatogr., B. 685, 113-122.
44. Nicholls, A. W., Akira, K., Lindon, J. C., Farrant, R. D., Wilson, I. D., Harding, J., Killick, D. A., and Nicholson, J. K. (1996) NMR spectroscopic and theoretical chemistry studies on the internal acyl migration reactions of the 1-O-acyl-β-D-glucopyranuronate conjugates of 2-, 3-, and 4-(trifluoromethyl)benzoic acids. Chem. Res. Toxicol. 9, 1414-1424.
45. Baba, A., and Yoshioka, T. (2009) Structure-activity relationships for degradation reaction of 1-β-O-acyl glucuronides: kinetic description and prediction of intrinsic electrophilic reactivity under physiological conditions. Chem. Res. Toxicol. 22, 158-172.
46. Yoshioka, T., and Baba, A. (2009) Structure-activity relationships for degradation reaction of 1-β-O-acyl glucuronides. Part 2: Electronic and steric descriptors predicting reactivity of 1-β-O-acyl glucuronides derived from benzoic acids. Chem. Res. Toxicol. 22, 1559-1569.
47. Taft, R. W., Jr. (1952) Linear free energy relationships from rates of esterification and hydrolysis of aliphatic and ortho-substituted benzoate esters. J. Am. Chem. Soc. 74, 2729-2732.
48. Bollenback, G. N., Long, J. W., Benjamin, D. G., and Lindquist, J. A. (1955) The synthesis of aryl-D-glucopyranosiduronic acids. J. Am. Chem. Soc. 77, 3310-3315.
49. Gottlieb, H. E., Kotlyar, V., and Nudelman, A. (1997) NMR chemical shifts of common laboratory solvents as trace impurities. J. Org. Chem. 62, 7512-7515.
50. Baba, A., and Yoshioka, T. (2006) Synthesis of 1-β-O-acyl glucuronides of diclofenac, mefenamic acid and (S)-naproxen by the chemoselective enzymatic removal of protecting groups from the corresponding methyl acetyl derivatives. Org. Biomol. Chem. 4, 3303-3310.
51. Baba, A., and Yoshioka, T. (2007) An improved chemo-enzymatic synthesis of 1-β-O-acyl glucuronides: highly chemoselective enzymatic removal of protecting groups from corresponding methyl acetyl derivatives. J. Org. Chem. 72, 9541-9549.
52. Illing, H. P. A., and Wilson, I. D. (1981) pH dependent formation of β-glucuronidase resistant conjugates from the biosynthetic ester glucuronide of isoxepac. Biochem. Pharmacol. 30, 3381-3384.
53. Sinclair, K. A., and Caldwell, J. (1982) The formation of b-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH. Biochem. Pharmacol. 31, 953-957.
54. Smith, P. C., Hasegawa, J., Langenduk, P. N. J, and Benet, L. Z. (1995) Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac. Drug Metab. Dispos. 13, 110-112.
55. Hasegawa, H., Akira, K., Shinohara, Y., Kasuya, Y., and Hashimoto, T. (2001) Kinetics of intramolecular acyl migration of 1β-O-acyl glucuronides of (R)- and (S)-2-phenylpropionic acids. Biol. Pharm. Bull. 24, 852-855.
56. Mortensen, R. W., Corcoran, O., Cornett, C., Sidermann, U. G., Lindon, J. C., Nicholson, J. K., and Hansen, S. H. (2001) S-Naproxen-β-1-O- acyl glucuronide degradation kinetics studies by stopped-flow high-performance liquid chromatography-1H NMR and high-performance liquid chromatography-UV. Drug Metab. Dispos. 29, 375-380.
57. Brown, H. C., McDaniel, D. H, and Häfliger, O. (1955) Dissociation Constant. In Determination of Organic Structures by Physical Methods (Braude, E. A., and Nachod, F. C., Eds.) pp 567-662, Academic Press, New York.
58. Taft, R. W., Jr. (1953) The general nature of the proportionality of polar effects of substituent groups in organic chemistry. J. Am. Chem. Soc. 75, 4231-4238.
59. Unger, S. H., and Hansch, C. (1976) Quantitative models of steric effects. Prog. Phys. Org. Chem. 12, 91-118.
60. MacPhee, J. A., Panaye, A., and Dubois, J.-E. (1978) A critical examination of the Taft steric parameter-Es. Definition of a revised, broader and homogeneous scale. Extension to highly congested alkyl groups. Tetrahedron 34, 3353-3562.
61. 13C NMR chemical shifts. IR absorption frequencies and rate coefficients of nucleophilic acyl substitutions. A novel explanation for the substituent dependence of reactivity. J. Chem. Soc., Perkin Trans. 2, 1497-1502.
62. 13C NMR chemical shifts, ν(C=O) frequncy values, charge densities, and isodesmic reactions to interpret substituent effects on reactivity. J. Org. Chem. 67, 6995-7003.
63. Volland, C., Sun, H., Dammeyer, J., and Benet, L. Z. (1991) Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. Drug Metab. Dispos. 19, 1080-1086.
64. Johnson, C. H., Wilson, I. D., Harding, J. R., Stachulski, A. V., Iddon, L., Nicholson, J. K., and Lindon, J. C. (2007) NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of ibuprofen ((±)-(R, S)-2-(4-isobutylphenyl)propanoic acid), ita metabolites, and analogues. Anal. Chem. 79, 8720-8727.
65. 1H NMR spectroscopy. Xenobiotica 35, 715-725.
66. Bischer, A., Zia-Amirhosseini, P., Iwaki, M., McDonagh, A. F., and Benet, L. Z. (1995) Stereoselective binding properties of naproxen glucuronide diastereomers to proteins. J. Pharmacokinet. Biopharm. 23, 379-395.
67. Berry, N. G., Iddon, L., Iqbal, M., Meng, X., Jayapal, P., Johnson, C. H., Nicholson, J. K., Lindon, J. C., Harding, J. R., Wilson, I. D., and Stachulski, A. V. (2009) Synthesis, transacylation kinetics and computational chemistry of a set of arylacetic 1β-O-acyl glucuronides. Org. Biomol. Chem. 7, 2525-2533.
68. Mortensen, R. W., Sidelmann, U. G., Tjørnelund, J., and Hansen, S. H. (2002) Stereospecific pH-dependent degradation kinetics of R- and S-Naproxen-β-1-O-acyl glucuronide. Chirality 14, 305-312.
69. Li, C., Benet, L. Z., and Grillo, M. P. (2002) Studies on the chemical reactivity of 2-phenylpropionic acid 1-O-acyl glucuronide and S-acyl-CoA thioester metabolites. Chem. Res. Toxicol. 15, 1309-1317.
70. Wiberg, K. B, and Laidig, K. E. (1987) Barriers to rotation adjacent to double bonds. 3. The C-O barrier in formic acid, methyl formate, acetic acid, and methyl acetate. The origin of ester and amide "resonance". J. Am. Chem. Soc. 109, 5935-5943.
71. Pawar, D. M., Khalil, A. A., Hooks, D. R., Collins, K., Elliott, T., Stafford, J., Smith, L., and Noe, E. A. (1998) E and Z conformations of esters, thiol esters, and amides. J. Am. Chem. Soc. 120, 2108-2112.
72. Hyneck, M. L., Muhafo, A., and Benet, L. Z. (1988) Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide. Drug Metab. Disipos. 23, 566-572.
73. Smith, P. C., Song, W. Q., and Rodriguez, R. J. (1992) Covalent binding of etodolac acyl glucuronide to albumin in vitro. Drug Metab. Dsipos. 20, 962-965.
74. Van Breemen, R. B., and Fenselau, C. C. (1986) Reaction of 1-O-acyl glucuronides with 4-(p-nitrobenzyl)pyridine. Drug Metab. Dispos. 14, 197-201.
75. Sallustio, B. C., Fairchild, B. A., and Pannall, P. R. (1977) Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-β-D-glucuronide. Drug Metab. Dispos. 25, 55-60.